Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,452,000 | 5,901,000 | 2,973,000 | 8,062,000 | 7,644,000 |
| Depreciation Amortization | 4,905,000 | 3,243,000 | 1,618,000 | 7,013,000 | 5,222,000 |
| Income taxes - deferred | -1,700,000 | -935,000 | -663,000 | -2,102,000 | -1,706,000 |
| Accounts receivable | N/A | N/A | N/A | -109,000 | N/A |
| Other Working Capital | -6,944,000 | -6,908,000 | -1,919,000 | -3,066,000 | -5,992,000 |
| Other Operating Activity | 643,000 | 452,000 | 326,000 | 2,946,000 | 855,000 |
| Operating Cash Flow | $6,356,000 | $1,753,000 | $2,335,000 | $12,744,000 | $6,023,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -323,000 | 1,747,000 | -2,720,000 | -2,869,000 | 1,322,000 |
| PPE Investments | -1,784,000 | -1,182,000 | -564,000 | -2,909,000 | -1,992,000 |
| Purchase Of Investment | -215,000 | -86,000 | -134,000 | -180,000 | -75,000 |
| Sale Of Investment | 6,815,000 | 6,456,000 | 6,393,000 | 8,610,000 | 5,032,000 |
| Other Investing Activity | 302,000 | 290,000 | 299,000 | 0 | -12,000 |
| Investing Cash Flow | $4,795,000 | $7,225,000 | $3,274,000 | $2,652,000 | $4,275,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -897,000 | -903,000 | -386,000 | 6,317,000 | 5,585,000 |
| Debt Issued | 3,687,000 | 3,687,000 | N/A | N/A | 0 |
| Debt Repayment | -3,750,000 | -3,750,000 | 0 | -2,250,000 | -2,250,000 |
| Dividend Paid | -7,326,000 | -4,882,000 | -2,437,000 | -9,512,000 | -7,132,000 |
| Other Financing Activity | -2,614,000 | -2,575,000 | -2,404,000 | -11,695,000 | -8,229,000 |
| Financing Cash Flow | $-10,900,000 | $-8,423,000 | $-5,227,000 | $-17,140,000 | $-12,026,000 |
| Exchange Rate Effect | 36,000 | 34,000 | -7,000 | -66,000 | -37,000 |
| Beginning Cash Position | 1,107,000 | 1,107,000 | 1,107,000 | 2,917,000 | 2,917,000 |
| End Cash Position | 1,394,000 | 1,694,000 | 1,481,000 | 1,107,000 | 1,152,000 |
| Net Cash Flow | $287,000 | $588,000 | $375,000 | $-1,810,000 | $-1,765,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,356,000 | 1,753,000 | 2,335,000 | 12,744,000 | 6,023,000 |
| Capital Expenditure | -1,784,000 | -1,182,000 | -564,000 | -2,909,000 | -1,992,000 |
| Free Cash Flow | 4,572,000 | 571,000 | 1,771,000 | 9,835,000 | 4,031,000 |